Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Conditions: Childhood Choroid Plexus Tumor; Childhood Ependymoblastoma; Childhood Grade III Meningioma; Childhood High-grade Cerebellar Astrocytoma; Childhood High-grade Cerebral Astrocytoma; Childhood Medulloepithelioma; Recurrent Childhood Anaplastic Astrocytoma; Recurrent Childhood Anaplastic Oligoastrocytoma; Recurrent Childhood Anaplastic Oligodendroglioma; Recurrent Childhood Brain Stem Glioma; Recurrent Childhood Cerebellar Astrocytoma; Recurrent Childhood Cerebral Astrocytoma; Recurrent Childhood Giant Cell Glioblastoma; Recurrent Childhood Glioblastoma; Recurrent Childhood Gliomatosis Cerebri; Recurrent Childhood Gliosarcoma; Recurrent Childhood Medulloblastoma; Recurrent Childhood Pineoblastoma; Recurrent Childhood Supratentorial Primitive Neuroectodermal TumorInterventions: Drug: palbociclib isethionate; Other: pharmacological study; Other: laboratory biomarker analysisSponsors: Pediatric Brain Tumor Consortium; National Cancer Institute (NCI)Recruiting - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Astrocytoma | Brain Stem Giloma | Brain Tumor | Cancer & Oncology | Glioma | Medulloblastoma | Men | Neurology | Pediatrics | Pineoblastoma | Research | Study